Low-dose total skin electron beam therapy for refractory cutaneous CD30 positive lymphoproliferative disorders

Neil Panjwani; Christopher H Yoo; Erica Wang; Michael S Khodadoust; Youn H Kim; Richard T Hoppe; Susan M Hiniker

doi:10.1080/09546634.2019.1628913

Low-dose total skin electron beam therapy for refractory cutaneous CD30 positive lymphoproliferative disorders

J Dermatolog Treat. 2021 Feb;32(1):101-103. doi: 10.1080/09546634.2019.1628913. Epub 2019 Jun 27.

Authors

Neil Panjwani¹, Christopher H Yoo¹, Erica Wang², Michael S Khodadoust³, Youn H Kim², Richard T Hoppe¹, Susan M Hiniker¹

Affiliations

¹ Department of Radiation Oncology, Stanford University, Stanford, CA, USA.
² Department of Dermatology, Stanford University, Stanford, CA, USA.
³ Department of Oncology, Stanford University, Stanford, CA, USA.

PMID: 31179774
DOI: 10.1080/09546634.2019.1628913

Abstract

We describe a case of a 48-year-old woman with a refractory cutaneous CD30 positive lymphoproliferative disorder treated successfully with total skin electron beam radiotherapy (TSEBT).

Keywords: CD30+ lymphoproliferative disorder; TSEBT.

Publication types

Case Reports

MeSH terms

Electrons / therapeutic use*
Female
Humans
Ki-1 Antigen / metabolism*
Lymphoproliferative Disorders / metabolism
Lymphoproliferative Disorders / pathology
Lymphoproliferative Disorders / radiotherapy*
Middle Aged
Radiotherapy Dosage
Recurrence
Skin / pathology

Substances

Ki-1 Antigen